Hemab Therapeutics ApS is an emerging biotech company supported by Novo Holdings A/S with the aim of developing novel treatments for rare and underserved bleeding disorders. Based in Copenhagen, the company is led by a team of drug developers and scientists with deep expertise in haemophilia. Hemab has exclusive licences to state-of-the-art antibody technologies from both Novo Nordisk A/S and Genmab A/S.

Biotechnology

Life Sciences

Pharmaceutical

Hemab

Hemab's headquarters in Copenhagen, Denmark

Benny Sorensen

Erik Bjornson

Joe Vogel

Kathryn Zwetchkenbaum

Jigar Amin

Mattias Häger

Cécile Bonvoisin

Prafull Gandhi

Henrik Østergaard

Mads Behrndt

John Maraganore

Linda Bain

Uya Chuluunbaatar

Christine Borowski

Jørgen Søberg Petersen

Mårten Steen

Laura Tadvalkar

Shan Wang

Camilla Petrycer Hansen

Dan Becker

Description

People (5)

Mads Behrndt

Jørgen Søberg Petersen

Prafull Gandhi

Heidi Dyreborg

Emil Poulsen